Tabula Rasa HealthCare, Inc.
$10.50+0.86%(+$0.09)
TickerSpark Score
67/100
80
Valuation
60
Profitability
35
Growth
60
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRHC research report →
52-Week Range100% of range
Low $3.15
Current $10.50
High $10.50
Companywww.tabularasahealthcare.com
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare.
- CEO
- Brian W. Adams
- IPO
- 2016
- Employees
- 1,027
- HQ
- Moorestown, NJ, US
Price Chart
+197.45% · this period
Valuation
- Market Cap
- $284.03M
- P/E
- -3.30
- P/S
- 0.95
- P/B
- -4.47
- EV/EBITDA
- -20.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.34%
- Op Margin
- -18.82%
- Net Margin
- -25.82%
- ROE
- 12130.82%
- ROIC
- -19.80%
Growth & Income
- Revenue
- $299.52M · -9.58%
- Net Income
- $-77,334,000 · 2.18%
- EPS
- $-3.18 · 6.19%
- Op Income
- $-56,382,000
- FCF YoY
- -8.29%
Performance & Tape
- 52W High
- $10.50
- 52W Low
- $3.15
- 50D MA
- $10.34
- 200D MA
- $7.57
- Beta
- 1.58
- Avg Volume
- 449.19K
Get TickerSpark's AI analysis on TRHC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 3, 23 | Mitchell Ronald Paul | sell | 17,896 |
| Nov 3, 23 | Mitchell Ronald Paul | sell | 61,436 |
| Nov 3, 23 | Purcell Michael J. | sell | 88,514 |
| Nov 3, 23 | Purcell Michael J. | sell | 50,808 |
| Nov 3, 23 | Schwartz Jonathan David | sell | 17,582 |
| Nov 3, 23 | Schwartz Jonathan David | sell | 60,806 |
| Nov 3, 23 | Schweitzer Pamela | sell | 53,579 |
| Nov 3, 23 | Schweitzer Pamela | sell | 25,641 |
| Nov 3, 23 | Schweitzer Pamela | sell | 9,784 |
| Nov 3, 23 | Helling Dennis | sell | 82,676 |
Our TRHC Coverage
We haven't published any research on TRHC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TRHC Report →